Literature DB >> 11510308

Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology.

N Ruperto1, A Ravelli, A Pistorio, C Malattia, S Cavuto, L Gado-West, A Tortorelli, J M Landgraf, G Singh, A Martini.   

Abstract

The aim of this project was to cross-culturally adapt and validate the American English version of the Childhood Health Assessment Questionnaire (CHAQ) and of the Child Health Questionnaire (CHQ) in the 32 different member countries of the Paediatric Rheumatology International Trials Organisation (PRINTO). This effort forms part of an international study supported by the European Union to evaluate the health-related quality of life in children with juvenile idiopathic arthritis (JIA) as compared to their healthy peers. A total of 6,644 subjects were enrolled from 32 countries: Argentina, Austria, Belgium, Brazil, Bulgaria, Chile, Croatia, the Czech Republic, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Korea, Latvia, Mexico, the Netherlands, Norway, Poland, Portugal, Russia, Slovakia, Spain, Sweden, Switzerland, Turkey, the United Kingdom, and Yugoslavia. A total of 3,235 patients had JIA (20% systemic onset, 33% polyarticular onset, 17% extended oligoarticular subtype, and 30% persistent oligoarticular subtype) while 3,409 were healthy children. This introductory paper describes the methodology used by all the participants. The results and the translated version of both the CHAQ and the CHQ for each country are fully reported in the following papers. The results of the present study show that cross-cultural adaptation is a valid process to obtain reliable instruments for the different socio-economic and socio-demographic conditions of the countries participating in the project.

Entities:  

Mesh:

Year:  2001        PMID: 11510308

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  86 in total

Review 1.  Update on outcome assessment in myositis.

Authors:  Lisa G Rider; Rohit Aggarwal; Pedro M Machado; Jean-Yves Hogrel; Ann M Reed; Lisa Christopher-Stine; Nicolino Ruperto
Journal:  Nat Rev Rheumatol       Date:  2018-04-12       Impact factor: 20.543

Review 2.  Network in pediatric rheumatology: the example of the Pediatric Rheumatology International Trials Organization.

Authors:  Nicolino Ruperto; Alberto Martini
Journal:  World J Pediatr       Date:  2008-08       Impact factor: 2.764

Review 3.  Quality of life in children with systemic lupus erythematosus.

Authors:  L Nandini Moorthy; Margaret Peterson; Karen B Onel; Melanie J Harrison; Thomas J A Lehman
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

4.  Cognitive profile and activities of daily living: 35 patients with alpha-mannosidosis.

Authors:  L Borgwardt; A M Thuesen; K J Olsen; J Fogh; C I Dali; A M Lund
Journal:  J Inherit Metab Dis       Date:  2015-05-28       Impact factor: 4.982

5.  Improvement of functional ability in children with juvenile idiopathic arthritis by treatment with etanercept.

Authors:  M Halbig; G Horneff
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

6.  Reliability and validity of the child health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population.

Authors:  H Raat; J M Landgraf; G J Bonsel; R J B J Gemke; M L Essink-Bot
Journal:  Qual Life Res       Date:  2002-09       Impact factor: 4.147

7.  Reliability and validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) in a general population and respiratory disease sample.

Authors:  Hein Raat; Jeanne M Landgraf; Rianne Oostenbrink; Henriëtte A Moll; Marie-Louise Essink-Bot
Journal:  Qual Life Res       Date:  2006-11-17       Impact factor: 4.147

8.  Comparing different revisions of the Childhood Health Assessment Questionnaire to reduce the ceiling effect and improve score distribution: Data from a multi-center European cohort study of children with JIA.

Authors:  W Groen; E Unal; M Nørgaard; S Maillard; J Scott; K Berggren; E Sandstedt; M Stavrakidou; J van der Net
Journal:  Pediatr Rheumatol Online J       Date:  2010-05-17       Impact factor: 3.054

9.  Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension.

Authors:  Nicolino Ruperto; Daniel J Lovell; Ruben Cuttica; Patricia Woo; Silvia Meiorin; Carine Wouters; Earl D Silverman; Zsolt Balogh; Michael Henrickson; Joyce Davidson; Ivan Foeldvari; Lisa Imundo; Gabriele Simonini; Joachim Oppermann; Stephen Xu; Yaung-Kaung Shen; Sudha Visvanathan; Adedigbo Fasanmade; Alan Mendelsohn; Alberto Martini; Edward H Giannini
Journal:  Ann Rheum Dis       Date:  2010-04       Impact factor: 19.103

10.  Turkish version of impact on family scale: a study of reliability and validity.

Authors:  Nilgun Bek; I Engin Simsek; Suat Erel; Yavuz Yakut; Fatma Uygur
Journal:  Health Qual Life Outcomes       Date:  2009-01-28       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.